144 related articles for article (PubMed ID: 34043677)
1. Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients.
Heilbroner SP; Xanthopoulos EP; Buono D; Carrier D; Durkee BY; Corradetti M; Wang TJC; Neugut AI; Hershman DL; Cheng SK
PLoS One; 2021; 16(5):e0252053. PubMed ID: 34043677
[TBL] [Abstract][Full Text] [Related]
2. Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung Cancer.
Kale MS; Mhango G; Bonomi M; Federman A; Sigel K; Rosenzweig KE; Wisnivesky JP
Ann Am Thorac Soc; 2016 Sep; 13(9):1593-9. PubMed ID: 27299697
[TBL] [Abstract][Full Text] [Related]
3. A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer.
Harris JP; Murphy JD; Hanlon AL; Le QT; Loo BW; Diehn M
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):872-84. PubMed ID: 24495591
[TBL] [Abstract][Full Text] [Related]
4. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
Sher DJ; Koshy M; Liptay MJ; Fidler MJ
Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer.
Sigel K; Lurslurchachai L; Bonomi M; Mhango G; Bergamo C; Kale M; Halm E; Wisnivesky J
Lung Cancer; 2013 Nov; 82(2):266-70. PubMed ID: 24011407
[TBL] [Abstract][Full Text] [Related]
6. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
[TBL] [Abstract][Full Text] [Related]
7. Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.
Jegadeesh N; Liu Y; Gillespie T; Fernandez F; Ramalingam S; Mikell J; Lipscomb J; Curran WJ; Higgins KA
Clin Lung Cancer; 2016 Sep; 17(5):398-405. PubMed ID: 26936682
[TBL] [Abstract][Full Text] [Related]
8. Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.
Shirvani SM; Jiang J; Gomez DR; Chang JY; Buchholz TA; Smith BD
Lung Cancer; 2013 Nov; 82(2):252-9. PubMed ID: 24018022
[TBL] [Abstract][Full Text] [Related]
9. Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy.
Koshy M; Malik R; Spiotto M; Mahmood U; Rusthoven CG; Sher DJ
Lung Cancer; 2017 Jun; 108():222-227. PubMed ID: 28625640
[TBL] [Abstract][Full Text] [Related]
10. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
Kwan SW; Mortell KE; Hippe DS; Brunner MC
J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
[TBL] [Abstract][Full Text] [Related]
11. Preoperative radiation may improve the outcomes of resectable IIIA/N2 non-small-cell lung cancer patients: A propensity score matching-based analysis from surveillance, epidemiology, and end results database.
Chen D; Wang H; Song X; Yue J; Yu J
Cancer Med; 2018 Sep; 7(9):4354-4360. PubMed ID: 30058192
[TBL] [Abstract][Full Text] [Related]
12. Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniques.
Jairam V; Pasha S; Soulos PR; Gross CP; Yu JB; Park HS; Decker RH
Lung Cancer; 2021 Nov; 161():171-179. PubMed ID: 34607209
[TBL] [Abstract][Full Text] [Related]
13. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.
Puri V; Crabtree TD; Kymes S; Gregory M; Bell J; Bradley JD; Robinson C; Patterson GA; Kreisel D; Krupnick AS; Meyers BF
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):428-36. PubMed ID: 22169443
[TBL] [Abstract][Full Text] [Related]
14. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in Chinese population: A retrospective study.
Xu Y; Zheng X; Bai X; Li P; Ma H; Wang J; Hu X; Chen M
Oncotarget; 2017 Jul; 8(30):49084-49092. PubMed ID: 28467775
[TBL] [Abstract][Full Text] [Related]
16. Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer.
Wang EH; Corso CD; Park HS; Chen AB; Wilson LD; Kim AW; Decker RH; Yu JB
Am J Clin Oncol; 2018 Feb; 41(2):152-158. PubMed ID: 26523443
[TBL] [Abstract][Full Text] [Related]
17. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
Wang D; Bi N; Zhang T; Zhou Z; Xiao Z; Liang J; Chen D; Hui Z; Lv J; Wang X; Wang X; Deng L; Wang W; Wang J; Wang C; Lu X; Xu K; Wu L; Xue W; Feng Q; Wang L
Radiat Oncol; 2019 Jun; 14(1):106. PubMed ID: 31196118
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
Chi A; Fang W; Sun Y; Wen S
JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
[TBL] [Abstract][Full Text] [Related]
19. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage I non-small-cell lung cancer.
Mitera G; Swaminath A; Rudoler D; Seereeram C; Giuliani M; Leighl N; Gutierrez E; Dobrow MJ; Coyte PC; Yung T; Bezjak A; Hope AJ
J Oncol Pract; 2014 May; 10(3):e130-6. PubMed ID: 24643574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
